Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP)

Journals

1. Wang S, Chen Q, Zhao T, Ai K, Hu C. Nanomedicine-based treatment: An emerging therapeutical strategy for pulmonary hypertension. Nano Research 2023;16(5):7007 View
2. Dlima S, Shevade S, Menezes S, Ganju A. Digital Phenotyping in Health Using Machine Learning Approaches: Scoping Review. JMIR Bioinformatics and Biotechnology 2022;3(1):e39618 View
3. Cassady S, Soldin D, Ramani G. Novel and emerging therapies in pulmonary arterial hypertension. Frontiers in Drug Discovery 2022;2 View
4. Lachant D, Light A, Lachant M, Annis J, Hemnes A, Brittain E, White R. Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension. Pulmonary Circulation 2023;13(3) View
5. Lachant D, White R. Wearable Devices in Pulmonary Arterial Hypertension: What Are We Trying to Learn?. Advances in Pulmonary Hypertension 2023;22(2):92 View
6. Lu M, Baima Y, Ni Z, Yang L, Zhang S, Zhang Y. Advances in the potential of nebulized inhalation for the treatment of pulmonary arterial hypertension. Current Problems in Cardiology 2024;49(10):102752 View
7. Robertson E, Naghavi N, Wipperman M, Tuckwell K, Effendi M, Alaj R, Urbanek J, Lederer D, Fredenburgh L, Stuart S. Digital measurement of mobility in pulmonary arterial hypertension: A structured review of an emerging area. DIGITAL HEALTH 2024;10 View